From: Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease
VHD group (n = 50)
Healthy control group (n = 55)
P
LVEDV (mL)
87.54 ± 14.87
75.41 ± 15.25
< 0.001
LVESV (mL)
54.41 ± 9.92
37.15 ± 8.11